Identification of a New Plasma Biomarker of Alzheimer Disease using Metabolomics Technology
Friday, January 06, 2012
This study by researchers from Eisai Co Ltd suggests that plasma desmosterol could be become a powerful new specific biomarker for the early and easy Alzheimers Disease diagnosis.
Pacific Biomarkers Announces New Chief Scientific Officer
Tuesday, January 03, 2012
Pacific Biomarkers names the company's current Vice President, Research and Development, Amar A. Sethi, MD, PhD, as the new Chief Scientific Officer.
Metabolon Granted Patent for Determining Metabolic Age of an Individual
Tuesday, January 03, 2012
Metabolon, Inc. announces the grant of EP Patent 2,089,539B entitled, “Biomarkers Related to Metabolic Age and Methods Using the Same.”
LMU-DCOM Announces Metabolomics Program
Friday, December 09, 2011
New unit to define disease biomarkers and study disease mechanisms.
Agilent Supports Russell Thomas’ Research at the Hamner Institutes for Health Sciences
Thursday, December 08, 2011
Russell supported for his work developing methods to predict drug-induced liver injury.
Agios Secures $78 Million in Oversubscribed Series C Financing
Tuesday, December 06, 2011
The proceeds will accelerate cancer metabolism programs and support expansion into new area of dysregulated metabolism.
Metabolon Receives Accreditation by College of American Pathologists
Tuesday, December 06, 2011
Metabolon, Inc. announces that they have received laboratory accreditation from the College of American Pathologists (CAP).
Metabolomics Study of Stepwise Hepatocarcinogenesis from the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma Diagnosis
Tuesday, December 06, 2011
Results from the study indicate that this metabolomics method has the potential of finding biomarkers for the early diagnosis of HCC.
Separation and Classification of Lipids using Differential Ion Mobility Spectrometry
Tuesday, December 06, 2011
In this study researchers from Pacific Northwest National Laboratory have shown how FAIMS could be applied to lipids, particularly in shotgun lipidomics and targeted analyses of bioactive lipids.
|
|
|
|
|
|
